What question did this study set out to answer?

To evaluate clinical characteristics, treatment patterns, and survival of patients with small lymphocytic lymphoma in British Columbia.

December 8, 2025BloodOpen Access

Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)

View Full Paper

Ask AI

Bookmark

Authors

Population-based analysis highlights survival and treatment patterns in small lymphocytic lymphoma with clinical implications.

To evaluate clinical characteristics, treatment patterns, and survival of patients with small lymphocytic lymphoma in British Columbia.
Population-based cohort study of newly diagnosed SLL patients from 1989 to 2024
Identified patients via provincial databases and defined them based on specific lymphocyte criteria
Conducted time-to-event analyses for overall survival and treatment-free survival
Compared subgroups using the log-rank test
Identified 676 patients with a median overall survival of 9.2 years
B symptoms and elevated LDH negatively impacted overall survival
First-line treatment included purine analog with Rituximab for 32% of patients
70% of patients received treatment by follow-up, median treatment-free survival was 1.6 years

Vanderveer et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark